Targeting Multiple Conserved T-Cell Epitopes for Protection against COVID-19 Moderate-Severe Disease by a Pan-Sarbecovirus Vaccine

Chang Yi Wang, Be-Sheng Kuo, Yu-Hsiang Lee, Yu-Hsin Ho, Yi-Hua Pan, Ya-Ting Yang, Hsi-Chi Chang, Lin-Fang Fu, Wen-Jiun Peng
doi: https://doi.org/10.1101/2023.06.28.23291948

Article Information

doi 
https://doi.org/10.1101/2023.06.28.23291948
History 
  • June 28, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Chang Yi Wang, PhD1,*,
  2. Be-Sheng Kuo, PhD1,
  3. Yu-Hsiang Lee, PhD1,
  4. Yu-Hsin Ho, MS1,
  5. Yi-Hua Pan, MS1,
  6. Ya-Ting Yang, MS1,
  7. Hsi-Chi Chang, MS1,
  8. Lin-Fang Fu, DVM, MS1 and
  9. Wen-Jiun Peng, PhD1
  1. 1UBI Asia, Hsinchu, Taiwan
  1. ↵*To whom correspondence should be addressed: cywang{at}ubiasia.com Chang Yi Wang, Ph.D. Chairperson, Chief Scientific Officer United Biomedical, Inc. Currently on assignment at UBI Asia based in Taiwan Tel: +886-963085800
Back to top
Posted June 28, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Targeting Multiple Conserved T-Cell Epitopes for Protection against COVID-19 Moderate-Severe Disease by a Pan-Sarbecovirus Vaccine
Chang Yi Wang, Be-Sheng Kuo, Yu-Hsiang Lee, Yu-Hsin Ho, Yi-Hua Pan, Ya-Ting Yang, Hsi-Chi Chang, Lin-Fang Fu, Wen-Jiun Peng
medRxiv 2023.06.28.23291948; doi: https://doi.org/10.1101/2023.06.28.23291948
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area